These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 8195365

  • 1. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
    Kleinman SH, Kaplan JE, Khabbaz RF, Calabro MA, Thomson R, Busch M.
    J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
    [Abstract] [Full Text] [Related]

  • 2. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
    Varma M, Rudolph DL, Knuchel M, Switzer WM, Hadlock KG, Velligan M, Chan L, Foung SK, Lal RB.
    J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB.
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a recombinant human T-cell lymphotropic virus type I (HTLV-I) p21E antibody detection enzyme immunoassay as a supplementary test in HTLV-I/II antibody testing algorithms.
    Hartley TM, Malone GE, Khabbaz RF, Lal RB, Kaplan JE.
    J Clin Microbiol; 1991 Jun; 29(6):1125-7. PubMed ID: 1864928
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
    Berini CA, Eirin ME, Pando MA, Biglione MM.
    J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sensitivity of two enzyme-linked immunosorbent assay tests in relation to western blot in detecting human T-cell lymphotropic virus types I and II infection among HIV-1 infected patients from São Paulo, Brazil.
    Caterino-de-Araujo A, de los Santos-Fortuna E, Meleiro MC, Suleiman J, Calabrò ML, Favero A, De Rossi A, Chieco-Bianchi L.
    Diagn Microbiol Infect Dis; 1998 Mar; 30(3):173-82. PubMed ID: 9572023
    [Abstract] [Full Text] [Related]

  • 12. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
    Abrams A, Akahata Y, Jacobson S.
    Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study.
    Busch MP, Laycock M, Kleinman SH, Wages JW, Calabro M, Kaplan JE, Khabbaz RF, Hollingsworth CG.
    Blood; 1994 Feb 15; 83(4):1143-8. PubMed ID: 8111054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Strategies for diagnosis of HTLV-I and -II.
    Thorstensson R, Albert J, Andersson S.
    Transfusion; 2002 Jun 15; 42(6):780-91. PubMed ID: 12147033
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors.
    Andrade RG, Ribeiro MA, Namen-Lopes MS, Silva SM, Basques FV, Ribas JG, Carneiro-Proietti AB, Martins ML.
    Rev Soc Bras Med Trop; 2010 Jun 15; 43(2):111-5. PubMed ID: 20464136
    [Abstract] [Full Text] [Related]

  • 17. Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
    Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, Barnett M, Drummond J, Waters D, Cerney M.
    Blood; 1991 Feb 15; 77(4):896-905. PubMed ID: 1993227
    [Abstract] [Full Text] [Related]

  • 18. Lack of specificity of HTLV antibody enzyme immunoassays.
    Jang D, Mahony JB, Sellors JW, Galli R, Gregory B, Chernesky MA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug 15; 9(5):523-4. PubMed ID: 7627628
    [No Abstract] [Full Text] [Related]

  • 19. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
    Campos KR, Gonçalves MG, Costa NA, Caterino-de-Araujo A.
    Braz J Infect Dis; 2017 Aug 15; 21(3):297-305. PubMed ID: 28343818
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.
    Vrielink H, Sisay Y, Reesink HW, Woerdeman M, Winkel C, de Leeuw SJ, Lelie PN, van der Poel CL.
    Transfus Med; 1995 Jun 15; 5(2):135-7. PubMed ID: 7655577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.